Skip to main content
. Author manuscript; available in PMC: 2014 Sep 10.
Published in final edited form as: AIDS. 2013 Sep 10;27(14):2181–2190. doi: 10.1097/QAD.0b013e3283639804

Figure 5. HIV-1 ± morphine, maraviroc, and/or a bivalent CCR5 antagonist did not affect the viability of primary human glia.

Figure 5

Cell viability of astrocytes (A) and microglia (B) were assessed after 24 h treatment by measurement of both live and dead cells using fluorescence labeling. Data are percent viable cells ± SEM from 3 independent experiments.